REPORTS

Let’s Pullulate and Expand Your Business

Opioids Market - Global Professional Analysis and Forecast to 2026

Oct 10, 2019  |  181 PAGES  |  REPORT CODE: CMM202566
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Opioids market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.0% during the forecast period.

This report presents the market size and development trends by detailing the Opioids market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Opioids market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Opioids industry and will help you to build a panoramic view of the industrial development.

Opioids Market, By Type:

  • Morphine

  • Hydrocodone

  • Codeine

  • Oxycodone

  • Others

Opioids Market, By Application:

  • Neuropathic Pain Treatment

  • Orthopedic Pain Treatment

  • Other Pain Treatment

Some of the leading players are as follows:

  • Endo Pharmaceuticals

  • Orexo Pharmaceuticals

  • Pfizer

  • Purdue Pharma

  • Allergan

  • Sun Pharmaceutical Industries Limited.

  • AbbVie

  • Teva pharmaceuticals

  • Sanofi

  • Hospira

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Opioids Market: Technology Type Analysis

  • 4.1 Opioids Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Opioids Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Morphine

    • 4.3.2 Hydrocodone

    • 4.3.3 Codeine

    • 4.3.4 Oxycodone

    • 4.3.5 Others

5 Opioids Market: Product Analysis

  • 5.1 Opioids Product Market Share Analysis, 2018 & 2026

  • 5.2 Opioids Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Opioids Market: Application Analysis

  • 6.1 Opioids Application Market Share Analysis, 2018 & 2026

  • 6.2 Opioids Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Neuropathic Pain Treatment

    • 6.3.2 Orthopedic Pain Treatment

    • 6.3.3 Other Pain Treatment

7 Opioids Market: Regional Analysis

  • 7.1 Opioids Regional Market Share Analysis, 2018 & 2026

  • 7.2 Opioids Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Endo Pharmaceuticals

    • 9.1.1 Endo Pharmaceuticals Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Orexo Pharmaceuticals

    • 9.2.1 Orexo Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer

    • 9.3.1 Pfizer Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Purdue Pharma

    • 9.4.1 Purdue Pharma Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Allergan

    • 9.5.1 Allergan Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Sun Pharmaceutical Industries Limited.

    • 9.6.1 Sun Pharmaceutical Industries Limited. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 AbbVie

    • 9.7.1 AbbVie Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Teva pharmaceuticals

    • 9.8.1 Teva pharmaceuticals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Hospira

    • 9.10.1 Hospira Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 87 Figures and 126 Tables)

  • Figure Morphine Opioids market, 2015 - 2026 (USD Million)

  • Figure Hydrocodone Opioids market, 2015 - 2026 (USD Million)

  • Figure Codeine Opioids market, 2015 - 2026 (USD Million)

  • Figure Oxycodone Opioids market, 2015 - 2026 (USD Million)

  • Figure Others Opioids market, 2015 - 2026 (USD Million)

  • Figure Neuropathic Pain Treatment market, 2015 - 2026 (USD Million)

  • Figure Orthopedic Pain Treatment market, 2015 - 2026 (USD Million)

  • Figure Other Pain Treatment market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Opioids market, by country, 2015 - 2026 (USD Million)

  • Table North America Opioids market, by type, 2015 - 2026 (USD Million)

  • Table North America Opioids market, by product, 2015 - 2026 (USD Million)

  • Table North America Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Opioids market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Opioids market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Canada Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Canada Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Europe Opioids market, by country, 2015 - 2026 (USD Million)

  • Table Europe Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Europe Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Europe Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Opioids market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Opioids market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Germany Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Germany Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Opioids market, by type, 2015 - 2026 (USD Million)

  • Table France Opioids market, by product, 2015 - 2026 (USD Million)

  • Table France Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Italy Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Italy Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Spain Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Spain Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Opioids market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Opioids market, by type, 2015 - 2026 (USD Million)

  • Table China Opioids market, by product, 2015 - 2026 (USD Million)

  • Table China Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Japan Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Japan Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Opioids market, by type, 2015 - 2026 (USD Million)

  • Table India Opioids market, by product, 2015 - 2026 (USD Million)

  • Table India Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Opioids market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Opioids market, by application, 2015 - 2026 (USD Million)

  • Table MEA Opioids market, by country, 2015 - 2026 (USD Million)

  • Table MEA Opioids market, by type, 2015 - 2026 (USD Million)

  • Table MEA Opioids market, by product, 2015 - 2026 (USD Million)

  • Table MEA Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Opioids market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Opioids market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Opioids market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Opioids market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Opioids market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Endo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Orexo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sun Pharmaceutical Industries Limited. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hospira Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top